Navigation Links
Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
Date:2/4/2008

results of any of the Company's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

COMPANY CONTACT: Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203) 498-4210 phone


'/>"/>
SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
3. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
5. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
6. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Access Pharmaceuticals Announces $2.7 Million New Equity
8. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
9. Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
10. Cylene Pharmaceuticals Appoints Kenna Anderes, Ph.D. as Vice President of Cancer Biology
11. Onyx Pharmaceuticals to Present at Wachovia Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 This ... perspectives on nonclinical and clinical safety assessment in ... to guide a path for biosimilar drug development, ... demonstration of biosimilarity with regards to quality, safety ... aspects of biosimilar drug development and registration, development ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory ... One of these latent viruses is the Epstein Barr ... arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory ... the theory, a study found that RA patients have ... , What is Microcompetition? , Dr. Hanan Polansky ...
(Date:1/15/2014)... AudioNotch is the internet's leading ... for the treatment of tinnitus. Patients listen to ... frequency, and over a period of weeks to months, ... Notched Sound Therapy in two forms: Notched Music and ... to release of a new form of Tailor-Made Notched ...
(Date:1/14/2014)... Diego, CA (PRWEB) January 14, 2014 ... solutions based on the products of cells grown ... have entered into an international license agreement with ... Histogen’s proprietary multipotent cell conditioned media (CCM). ... the existing license between Histogen and Suneva Medical, ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... SAN DIEGO, April 10 MedImmune today announced ... oncology,portfolio programs at the Annual Meeting of the ... commitment to,excellence in oncology research., "Cancer research ... at MedImmune and we,are proud to share data ...
... -- Sinovac Biotech Ltd. (Amex:,SVA), a leading provider ... General Meeting originally scheduled for March 25, 2008 ... During the April 8, 2008 Annual General ... Shangdi Xi Rd., Haidian District, Beijing,PRC, resolutions for ...
... CHICAGO, April 10 Advanced Life Sciences,Holdings, Inc. ... on a productive,meeting with the U.S. Food and ... New Drug Application (NDA) in the third quarter ... to treat mild-to-moderate,community acquired pneumonia (CAP)., (Logo: ...
Cached Biology Technology:MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 2MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 3Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 2Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 3
(Date:4/15/2014)... The global experts who study the deadliest infectious diseases ... G. Ksiazek, professors at the University of Texas Medical ... annual International Symposium on Filoviruses. The filoviruses include Ebola ... 90 percent of people infected. The current outbreak of ... than 100 deaths so far. , "This award ...
(Date:4/15/2014)... nanoparticle form could help reduce side effects by targeting ... scientists have developed nanoparticles that deliver one or two ... design particles that can carry any more than that ... devised a new way to build such nanoparticles, making ... drugs. In a paper published in the Journal ...
(Date:4/15/2014)... of Adelaide research into parasites of cuttlefish, squid ... astonishing life cycles, and shown how they may ... Researcher Dr Sarah Catalano has described 10 new ... the kidneys of cephalopods (cuttlefish, squid and octopus). ... to be described from Australian waters. , ...
Breaking Biology News(10 mins):International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Bizarre parasite may provide cuttlefish clues 2
... anti-cancer drugs block the enzymes that snip the kinks and ... cells but the drugs are increasingly encountering resistant bacteria ... Berkeley, biochemists could pave the way for new research into ... poisons for cancer cells and harmful bacteria. "The development ...
... foods is a top priority in tackling the obesity epidemic ... six months, the Institute of Medicine, United States Department of ... taken an interest in improving access to affordable and nutritious ... of epidemiology, and his team are tackling the same issue. ...
... Institute for Brain Science announced today that it has launched ... charting genes at work throughout the human brain. The ... extensive and detailed body of information about gene activity in ... or "turned on" where. In the coming years, the ...
Cached Biology News:Preventing cells from getting the kinks out of DNA 2Preventing cells from getting the kinks out of DNA 3Obesity remains an economic issue, Seattle obesity study finds 2Obesity remains an economic issue, Seattle obesity study finds 3Allen Institute for Brain Science launches Allen Human Brain Atlas 2Allen Institute for Brain Science launches Allen Human Brain Atlas 3
Intestinal Epithelium Differentiation Environment...
...
The Programmable MP-5000P-F Power Supply can be applied for any Microfluidic application....
... Drummond Scientific has a long and ... microinjection apparatus. Several years ago we ... displacement microdispenser was being modified to ... unit by redesigning the microdispenser to ...
Biology Products: